After an explosive start to the year, Hims & Hers Health, Inc. (HIMS) is now trading in an intermediate-term range above long-term support from the weekly cloud model (shaded area on the chart) and the 200-day (~40-week) moving average, both of which define the stock's cyclical uptrend. The uptrend remains healthy and is supported by positive long-term momentum, providing a bullish outlook through year-end. HIMS's long-term technical strength aligns with a bullish fundamental view from personal investing pro Austin Hankwitz , who notes: "Their stock is attractive in my view as annual revenue is expected to grow by +134% to $3.5B by 2027. Their total addressable market exceeds $25B+ per year, leaving plenty of runway for this innovative company." A rally off long-term support has turned the

See Full Page